Due to restrictions following results are derived from synthetic data to demonstrate capability of Computational Healthcare. Please do no derive any inferences from results below.

Rehospitalizations

Numerator 360

Discharged

Denominator 810

Rehospitalization Rate

360 / 810 = 44.4 %

Index = Discharged + Died + Transferred

970 (100%) = 810 (83.5%) + 0 (0.0%) + 0 (0.0%)

Aggregation Policy
Minimum count20
Multiple10
Min hospitals2
Min subset200

Rehospitalization during 50 days since discharge:

Mean ΔT: 62.74 days FQ: 10 days Median: 28 days TQ: 82 days

Rehospitalization during 50 weeks since discharge:

Mean ΔT: 8.54 weeks FQ: 1 weeks Median: 4 weeks TQ: 11 weeks
Sex Distribution
Sex Initial Sub Discharged
Male 58.33 % 58.33 % 58.02 %
Female 38.89 % 38.89 % 41.98 %
Race Distribution
Race Initial Sub Discharged
White 11.11 % 13.89 % 12.35 %
Black 13.89 % 11.11 % 14.81 %
Hispanic 11.11 % 16.67 % 14.81 %
Asian or Pacific Islander 11.11 % 13.89 % 14.81 %
Native American 13.89 % 16.67 % 13.58 %
Other 13.89 % 11.11 % 13.58 %
Race missing, unknown 16.67 % 13.89 % 14.81 %
Payer Distribution
Payer Initial Sub Discharged
Medicare 11.11 % 11.11 % 13.58 %
Medicaid 11.11 % 13.89 % 14.81 %
Private insurance 13.89 % 13.89 % 13.58 %
Self-pay 13.89 % 11.11 % 12.35 %
Other payer 13.89 % 13.89 % 14.81 %
Unknown payer 11.11 % 13.89 % 11.11 %
No charge 13.89 % 16.67 % 16.05 %
Source Distribution
Source Initial Sub Discharged
Another health facility including LTC 16.67 % 16.67 % 17.28 %
Emergency department 16.67 % 13.89 % 17.28 %
Unknown 13.89 % 13.89 % 16.05 %
Court/Law enforcement 16.67 % 16.67 % 16.05 %
Routine, birth, etc 16.67 % 13.89 % 16.05 %
Another hospital 13.89 % 13.89 % 14.81 %
Disposition Distribution
Disposition Initial Sub Discharged
Home Health Care 13.89 % 13.89 % 16.05 %
Died in hospital 0.0 % 11.11 % 0.0 %
Transfer other SNF, ICF, etc. 11.11 % 11.11 % 16.05 %
Routine 72.22 % 52.78 % 65.43 %
Length of Stay Distribution
Discharged
Initial
Subsequent
Visits Mean LOS First quartile Median Third quartile
Discharged 7.89 days 3 days 6 days 10 days
Initial 7.95 days 3 days 6 days 10 days
Sub 8.8 days 3 days 5 days 11 days
Age Distribution
Discharged
Initial
Subsequent
Visits Mean Age First quartile Median Third quartile
Discharged 73.44 year 64 year 76 year 85 year
Initial 71.59 year 62 year 73 year 84 year
Sub 71.79 year 62 year 74 year 84 year
Procedure Distribution
Procedure Code Description Initial Sub Discharged
P8607 Insertion of totally implantable vascular access device [VAD] 5.56 % 0.0 % 4.94 %
P4516 Esophagogastroduodenoscopy [EGD] with closed biopsy 0.0 % 0.0 % 4.94 %
P3491 Thoracentesis 5.56 % 0.0 % 4.94 %
P8741 Computerized axial tomography of thorax 0.0 % 0.0 % 2.47 %
P4131 Biopsy of bone marrow 27.78 % 0.0 % 23.46 %
P9905 Transfusion of platelets 5.56 % 8.33 % 6.17 %
P9904 Transfusion of packed cells 30.56 % 30.56 % 30.86 %
P9925 Injection or infusion of cancer chemotherapeutic substance 25.0 % 22.22 % 19.75 %
P3893 Venous catheterization, not elsewhere classified 16.67 % 16.67 % 14.81 %
P8872 Diagnostic ultrasound of heart 0.0 % 0.0 % 3.7 %
P0331 Spinal tap 0.0 % 0.0 % 2.47 %
P8801 Computerized axial tomography of abdomen 0.0 % 0.0 % 3.7 %
P5424 Closed [percutaneous] [needle] biopsy of intra-abdominal mass 0.0 % 0.0 % 2.47 %
P9229 Other radiotherapeutic procedure 0.0 % 0.0 % 2.47 %
DRG Distribution
DRG Code Description Initial Sub Discharged
DG410 DRG V24 : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS 0.0 % 8.33 % 0.0 %
DG576 DRG V24 : SEPTICEMIA W/O MV 96+ HOURS AGE >17 0.0 % 5.56 % 0.0 %
DG403 DRG V24 : LYMPHOMA & NON-ACUTE LEUKEMIA W CC 100.0 % 19.44 % 100.0 %
Diagnosis Distribution
Diagnosis Code Description Initial Primary Sub Primary Discharged Primary Initial All Sub All Discharged All
D20510 Chronic myeloid leukemia, without mention of having achieved remission 0.0% 0.0% 3.7% 0.0% 0.0% 0.0%
D2387 Description not found for D2387 0.0% 0.0% 3.7% 0.0% 0.0% 2.47%
DV1582 Personal history of tobacco use 0.0% 0.0% 0.0% 5.56% 5.56% 6.17%
D4280 Congestive heart failure, unspecified 0.0% 0.0% 0.0% 5.56% 0.0% 4.94%
D311 Depressive disorder, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D5859 Chronic kidney disease, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D496 Chronic airway obstruction, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D25000 Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled 0.0% 0.0% 0.0% 5.56% 5.56% 6.17%
D28529 Anemia of other chronic disease 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D53081 Esophageal reflux 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D2639 Unspecified protein-calorie malnutrition 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D28522 Anemia in neoplastic disease 0.0% 0.0% 0.0% 8.33% 5.56% 6.17%
D5849 Acute kidney failure, unspecified 0.0% 0.0% 0.0% 8.33% 5.56% 6.17%
D5119 Unspecified pleural effusion 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D486 Pneumonia, organism unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D40390 Hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage I through stage IV, or unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D3051 Tobacco use disorder 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D2848 Description not found for D2848 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D27651 Dehydration 0.0% 0.0% 0.0% 8.33% 8.33% 7.41%
D2841 Pancytopenia 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D1962 Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes 0.0% 0.0% 2.47% 0.0% 0.0% 0.0%
D60000 Hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (LUTS) 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D5990 Urinary tract infection, site not specified 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D20410 Chronic lymphoid leukemia, without mention of having achieved remission 5.56% 0.0% 6.17% 0.0% 0.0% 3.7%
D4019 Unspecified essential hypertension 0.0% 0.0% 0.0% 13.89% 13.89% 19.75%
D41401 Coronary atherosclerosis of native coronary artery 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D20300 Multiple myeloma, without mention of having achieved remission 16.67% 5.56% 18.52% 8.33% 11.11% 9.88%
D2768 Hypopotassemia 0.0% 0.0% 0.0% 0.0% 5.56% 3.7%
D73313 Pathologic fracture of vertebrae 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
DV5811 Encounter for antineoplastic chemotherapy 0.0% 8.33% 0.0% 0.0% 5.56% 0.0%
D20288 Other malignant lymphomas, lymph nodes of multiple sites 0.0% 0.0% 3.7% 0.0% 0.0% 0.0%
D2761 Hyposmolality and/or hyponatremia 0.0% 0.0% 0.0% 5.56% 0.0% 4.94%
D20282 Other malignant lymphomas, intrathoracic lymph nodes 0.0% 0.0% 2.47% 0.0% 0.0% 0.0%
D20283 Other malignant lymphomas, intra-abdominal lymph nodes 8.33% 0.0% 7.41% 0.0% 0.0% 3.7%
D20280 Other malignant lymphomas, unspecified site, extranodal and solid organ sites 13.89% 5.56% 14.81% 8.33% 11.11% 8.64%
D56400 Constipation, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D42731 Atrial fibrillation 0.0% 0.0% 0.0% 0.0% 0.0% 2.47%
D2724 Other and unspecified hyperlipidemia 0.0% 0.0% 0.0% 5.56% 0.0% 6.17%
D27542 Hypercalcemia 0.0% 0.0% 0.0% 0.0% 0.0% 3.7%
D2859 Anemia, unspecified 0.0% 0.0% 0.0% 8.33% 8.33% 7.41%
D2449 Unspecified acquired hypothyroidism 0.0% 0.0% 0.0% 0.0% 0.0% 4.94%
D2875 Thrombocytopenia, unspecified 0.0% 0.0% 0.0% 5.56% 0.0% 6.17%
External Causes Distribution
External Cause Code Description Initial Sub Discharged
EE9331 Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 8.33 % 19.44 % 8.64 %
EE8499 Accidents occurring in unspecified place 0.0 % 0.0 % 2.47 %
EE8490 Accident in home 5.56 % 11.11 % 6.17 %
EE8497 Accidents occurring in residential institution 11.11 % 13.89 % 11.11 %